Physician profile
Mark Mcdonnell
NPI 1477526374
$739.74
in general payments reported to CMS, 2019-2025
11 companies · $56.96 in 2025
The $56.96 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.47 · 2020: $103 · 2021: $64.62 · 2022: $223 · 2023: $151 · 2024: $109 · 2025: $56.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $289.78 | 2019-2024 | Salvation, Hoffmann, Valor |
| Anika Therapeutics, INC. | $114.08 | 2023 | Tactoset, X-Twist |
| Arthrex, INC. | $88.45 | 2022 | |
| Zimmer Biomet Holdings, INC. | $77.68 | 2020 | |
| Abbott Laboratories | $35.75 | 2023-2024 | Proclaim, Octrode |
| Mimedx Group, INC. | $29.56 | 2025 | |
| Axogen | $27.40 | 2025 | Axoguard Ha+ Nerve Protector |
| Smith+Nephew, INC. | $25.53 | 2020 | |
| Heron Therapeutics, INC. | $18.38 | 2021 | |
| Bioventus LLC | $16.67 | 2021 | |
| Medtronic, INC. | $16.46 | 2023 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mcdonnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.